Bora Pharmaceuticals set to shake up rare disease treatment with Pyros Pharmaceuticals acquisition
Bora Pharmaceuticals Co., Ltd. is intensifying its presence in the rare disease treatment market by acquiring U.S.-based Pyros Pharmaceuticals, a company focused on specialized rare disease therapies. This acquisition, recently approved by Bora’s board of directors, positions Bora Pharmaceuticals to become a leader in addressing rare but critical medical conditions. Pyros Pharmaceuticals, co-founded by Michael […]